TIGR, GOTU and DTIL among pre market gainers
franckreporter/iStock via Getty Images
- Cyren (CYRN) +39% on €10M sale of secure email gateway unit.
- Redbox Entertainment (RDBX) +25%.
- DBV Technologies (DBVT) +19% phase 3 trial for peanut allergy treatment in toddlers meets main goal.
- Brenmiller Energy (BNRG) +16%.
- Energy Focus (EFOI) +15%.
- Aldeyra Therapeutics (ALDX) +13% as dry eye disease drug meets main goal in late stage study.
- Full Truck Alliance (YMM) +10% on Q1 results.
- Precision BioSciences (DTIL) +10% provides update on allogeneic CAR T programs and path forward with its lead PBCAR0191 candidate for CAR T relapsed patient population.
- Jiayin Group (JFIN) +10% on Q1 results.
- Katapult Holdings (KPLT) +9% CEO buys shares worth ~$200K.
- Lizhi (LIZI) +9%.
- Novavax (NVAX) +8% as analysts cheer FDA backing for COVID-19 shot.
- Bilibili (BILI) +8% Alibaba, JD.com, Bilibili rise as China approves second group of video games.
- Broadway Financial (BYFC) +8%.
- Roku (ROKU) +7% it 'abruptly' closes trading window, talk of Netflix deals swirls: report
- Dynamics Special Purpose (DYNS) +7%.
- Unicycive Therapeutics (UNCY) +7%.
- Gaotu Techedu (GOTU) +6%.
- Siyata Mobile (SYTA) +6%.
- HUTCHMED (HCM) +6%.
- Eos Energy (EOSE) +6%.
- UP Fintech Holding (TIGR) +5%.